Circulating PCSK9 levels were elevated in patients with histologically proven liver steatosis [66], and a positive correlation with the hepatic expression of genes involved in de novo lipogenesis, necroinflammation and fibrosis stages were identified [66]. This evidence concerns the gene PCSK9 and fatty liver disease.